Tetragon Partners GP Ltd

Tetragon Partners GP Ltd reported 43 holdings worth US$635M as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 13, 2026

Tetragon Partners GP Ltd reported 43 holdings worth US$635M as of Jun 30, 2026. Largest: Uipath, Inc., Kolibri Global Energy Inc and Lyft, Inc. Filed Aug 13, 2026 (Form 13F).

Holdings
43
Value as reported
US$635M

The filing in full

CompanySharesValue as reported% of portfolio
Uipath, Inc.30.9MUS$336M53.0%
Kolibri Global Energy Inc6.83MUS$33.8M5.3%
Lyft, Inc.1MUS$14.6M2.3%
Definium Therapeutics, Inc.287KUS$13.5M2.1%
Workiva Inc.250KUS$12.1M1.9%
Sprinklr, Inc.2.2MUS$11.4M1.8%
Mbx Biosciences, Inc.204KUS$11.2M1.8%
Alkami Technology, Inc.600KUS$10.9M1.7%
Celldex Therapeutics, Inc.290KUS$10.8M1.7%
Relay Therapeutics, Inc.570KUS$10.7M1.7%
Arrowhead Pharmaceuticals, Inc.130KUS$10.6M1.7%
Immunovant, Inc.256KUS$9.86M1.6%
Dyne Therapeutics, Inc.357KUS$7.92M1.2%
Ionis Pharmaceuticals, Inc.97,173US$7.7M1.2%
Agios Pharmaceuticals, Inc.206KUS$7.63M1.2%
Harmony Biosciences Holdings, Inc.201KUS$7.32M1.2%
Krystal Biotech, Inc.19,668US$7.31M1.2%
Annexon, Inc.1.24MUS$7.09M1.1%
Celcuity Inc.64,110US$6.71M1.1%
Warner Bros. Discovery, Inc. - Series A250KUS$6.67M1.0%
Nektar Therapeutics86,996US$6.07M0.96%
Amylyx Pharmaceuticals, Inc.298KUS$5.35M0.84%
Acadia Pharmaceuticals Inc.168KUS$4.25M0.67%
Cue Biopharma, Inc.93,819US$2.96M0.47%
Snowflake Inc.10,000US$2.54M0.40%
Aclaris Therapeutics, Inc.400KUS$2.12M0.33%
Tectonic Therapeutic, Inc.46,516US$1.6M0.25%
Monte Rosa Therapeutics, Inc.56,052US$1.36M0.21%
Praxis Precision Medicines, Inc.0US$00.00%
Soleno Therapeutics, Inc.0US$00.00%
Ultragenyx Pharmaceutical Inc.0US$00.00%
Aardvark Therapeutics, Inc.0US$00.00%
Axsome Therapeutics, Inc.0US$00.00%
Karyopharm Therapeutics Inc.0US$00.00%
Maplight Therapeutics, Inc.0US$00.00%

Source

View original at SEC

Related